The protease MT1-MMP drives a combinatorial proteolytic program in activated endothelial cells.

TitleThe protease MT1-MMP drives a combinatorial proteolytic program in activated endothelial cells.
Publication TypeJournal Article
Year of Publication2012
AuthorsKoziol, A, Gonzalo, P, Mota, A, Pollán, A, Lorenzo, C, Colomé, N, Montaner, D, Dopazo, J, Arribas, J, Canals, F, Arroyo, AG
JournalFASEB J
Volume26
Issue11
Pagination4481-94
Date Published2012 Nov
ISSN1530-6860
KeywordsAnimals; Blotting, Western; Combinatorial Chemistry Techniques; Computational Biology; Endothelial Cells; Gene Expression Regulation, Enzymologic; Inflammation; Matrix Metalloproteinase 14; Mice; Protein Array Analysis; Reverse Transcriptase Polymerase Chain Reaction; RNA Interference; RNA, Small Interfering; Transcriptome; Tumor Necrosis Factor-alpha
Abstract

The mechanism by which proteolytic events translate into biological responses is not well understood. To explore the link of pericellular proteolysis to events relevant to capillary sprouting within the inflammatory context, we aimed at the identification of the collection of substrates of the protease MT1-MMP in endothelial tip cells induced by inflammatory stimuli. We applied quantitative proteomics to endothelial cells (ECs) derived from wild-type and MT1-MMP-null mice to identify the substrate repertoire of this protease in TNF-α-activated ECs. Bioinformatics analysis revealed a combinatorial MT1-MMP proteolytic program, in which combined rather than single substrate processing would determine biological decisions by activated ECs, including chemotaxis, cell motility and adhesion, and vasculature development. MT1-MMP-deficient ECs inefficiently processed several of these substrates (TSP1, CYR61, NID1, and SEM3C), validating the model. This novel concept of MT1-MMP-driven combinatorial proteolysis in angiogenesis might be extendable to proteolytic actions in other cellular contexts.

DOI10.1096/fj.12-205906
Alternate JournalFASEB J
PubMed ID22859368